Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: United States, China, Germany, Japan, Europe
The Pharmaceuticals market in South Korea has been experiencing substantial growth in recent years.
Customer preferences: South Korean consumers are increasingly interested in preventative healthcare, leading to a rise in demand for over-the-counter medications and supplements. Additionally, the aging population has created a higher demand for prescription medications.
Trends in the market: One trend in the South Korean Pharmaceuticals market is the increasing use of technology in healthcare. This includes telemedicine and mobile health apps, which allow patients to receive medical advice and prescriptions without leaving their homes. Another trend is the rise of biosimilars, which are similar but not identical versions of biologic drugs. Biosimilars are becoming more popular due to their lower cost compared to the original biologic drugs.
Local special circumstances: South Korea has a strong government-led healthcare system, with the government playing a significant role in regulating drug prices and approving new drugs. Additionally, cultural beliefs around healthcare may differ from other countries, with a greater emphasis on traditional medicine and natural remedies.
Underlying macroeconomic factors: The South Korean economy has been growing steadily in recent years, with a focus on innovation and technology. This has led to increased investment in the healthcare sector and the development of new drugs and treatments. Additionally, the government has implemented policies to encourage research and development in the pharmaceutical industry. However, the market is also facing challenges such as increasing competition and regulatory hurdles.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)